|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Lymphoma | |||||
| Myeloma | |||||
| Leukemia | |||||
| 2 | More general conditions related to this trial | ||||
| Immune System Diseases | |||||
| Immunoproliferative Disorders | |||||
| Lymphatic Diseases | |||||
| Lymphoproliferative Disorders | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| 3 | Interventions listed in this trial | ||||
| NK-Cell Infusion | |||||
| 4 | Sponsors listed in this trial | ||||
| Tufts Medical Center | |||||
| University of Minnesota | |||||